+++
bio = ""
date = "2018-04-30"
id = "s-shixiang"
interests = ["Biomarker Discovery", "Cancer Informatics", "Bioinformatics", "Machine Learning"]
name = "Shixiang Wang"
portrait = "/portraits/shixiang.jpg"
short_bio = "Be be or not be be, it's also a question"
short_name = "shixiang"
title = "Shixiang Wang"
sort_position = 4

[[social]]
    icon = "envelope"
    icon_pack = "fa"
    link = "mailto:wangshx@shanghaitech.edu.cn"

[[social]]
    icon = "twitter"
    icon_pack = "fa"
    link = "//twitter.com/ShixiangWang"

[[social]]
    icon = "github"
    icon_pack = "fa"
    link = "//github.com/ShixiangWang"

[[education]]
    course = "B.E. in Biomedical Engineering"
    institution = 'University of Electronic Science and Technology of China'
    year = 2016

#[[education]]
#    course = "PhD in Life and Science Technology"
#    institution = 'ShanghaiTech. University'
#    year = 2021 

[[organizations]]
    name = "ShanghaiTech. University"
    role = "PhD Student"

+++

Shixiang Wang is a Ph.D. student of Cancer Informatics at ShanghaiTech. University. Shixiang Wang’s interests include immunotherapy genomics, [development of R/Python/Linux tools](https://shixiangwang.github.io/home/en/tools/), knowledge sharing, and machine learning, etc.

## Publications

1. Wang, S., He, Z., Wang, X., Li, H., & Liu, X. S. (2019). Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction. eLife, 8.

1. Wang, S., Cowley, L. A. & Liu, X. S. (2019). Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy. Molecules 2019, 24(18), 3214.

1. Wang, S., & Liu, X. (2019). The UCSCXenaTools R package: a toolkit for accessing genomics data from UCSC Xena platform, from cancer multi-omics to single-cell RNA-seq. Journal of Open Source Software, 4(40), 1627.

1. He, Z., Wang, S., Shao, Y., Zhang, J., Wu, X., Chen, Y., ... & Liu, X. S. (2019). Ras Downstream Effector GGCT Alleviates Oncogenic Stress. iScience, 19, 256-266.

1. Wang, S., Zhang, J., He, Z., Wu, K., & Liu, X. S. (2019). The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients’ sex. International journal of cancer.

1. Wang S, Jia M, He Z, Liu XS. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer. Oncogene. 2018 Apr 26. doi: 10.1038/s41388-018-0245-9. 
